Biotechnology Industry Organization (BIO) Release: Biotech Leader Testifies at Congressional Hearing on ‘Reducing Barriers to Capital Formation’
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
WASHINGTON--(BUSINESS WIRE)--Today, the House Financial Services' Subcommittee on Capital Markets and Government Sponsored Enterprises held a hearing on “Reducing Barriers to Capital Formation, Part II.” Kenneth I. Moch, President and Chief Executive Officer of Chimerix, Inc. and a member of BIO’s Emerging Companies Section Governing Board, presented testimony at the hearing on market structure reforms that can decrease the cost of capital and increase liquidity for emerging biotech companies trading on the public market.
Help employers find you! Check out all the jobs and post your resume.
WASHINGTON--(BUSINESS WIRE)--Today, the House Financial Services' Subcommittee on Capital Markets and Government Sponsored Enterprises held a hearing on “Reducing Barriers to Capital Formation, Part II.” Kenneth I. Moch, President and Chief Executive Officer of Chimerix, Inc. and a member of BIO’s Emerging Companies Section Governing Board, presented testimony at the hearing on market structure reforms that can decrease the cost of capital and increase liquidity for emerging biotech companies trading on the public market.
Help employers find you! Check out all the jobs and post your resume.